Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1041.

Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase.

Proc. Natl. Acad. Sci. U.S.A.
Yuan ZM, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R, Kufe D.
| Feb 18, 1997
1042.

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia.

Nature.
He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D.
| Feb 13, 1997
1043.

Expression genetics in cancer: shifting the focus from DNA to RNA.

Proc. Natl. Acad. Sci. U.S.A.
Sager R.
| Feb 4, 1997
1044.

Association of BRCA1 with Rad51 in mitotic and meiotic cells.

Cell.
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM.
| Jan 24, 1997
1045.

A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair.

Cell.
Tishkoff DX, Filosi N, Gaida GM, Kolodner RD.
| Jan 24, 1997
1046.

Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.

Proc. Natl. Acad. Sci. U.S.A.
Stuhler G, Schlossman SF.
| Jan 21, 1997
1047.

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

Proc. Natl. Acad. Sci. U.S.A.
Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, Brun RP, Mueller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM.
| Jan 7, 1997
1048.

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.

Science.
Hu E, Kim JB, Sarraf P, Spiegelman BM.
| Dec 20, 1996
1049.

Progress in rectal cancer.

Lancet.
Fuchs CS.
| Dec 14, 1996
1050.

The leucine zipper may induce electrophoretic mobility anomalies without DNA bending.

Proc. Natl. Acad. Sci. U.S.A.
McCormick RJ, Badalian T, Fisher DE.
| Dec 10, 1996
1051.

Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells.

Nat. Med.
Gimmi CD, Morrison BW, Mainprice BA, Gribben JG, Boussiotis VA, Freeman GJ, Park SY, Watanabe M, Gong J, Hayes DF, Kufe DW, Nadler LM.
| 12 1, 1996
1052.

BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway.

Proc. Natl. Acad. Sci. U.S.A.
Strobel T, Swanson L, Korsmeyer S, Cannistra SA.
| Nov 26, 1996
1053.

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

JAMA.
Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjöld M, Komminoth P, Hendy GN, Mulligan LM.
| Nov 20, 1996
1054.

An essential role for p300/CBP in the cellular response to hypoxia.

Proc. Natl. Acad. Sci. U.S.A.
Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM.
| Nov 12, 1996
1055.

Adipogenesis and obesity: rounding out the big picture.

Cell.
Spiegelman BM, Flier JS.
| Nov 1, 1996
1056.

Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.

Proc. Natl. Acad. Sci. U.S.A.
Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ.
| Oct 15, 1996
1057.

The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.

Proc. Natl. Acad. Sci. U.S.A.
Xia K, Mukhopadhyay NK, Inhorn RC, Barber DL, Rose PE, Lee RS, Narsimhan RP, D'Andrea AD, Griffin JD, Roberts TM.
| Oct 15, 1996
1058.

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.

Proc. Natl. Acad. Sci. U.S.A.
Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R.
| Oct 15, 1996
1059.

p300 is a component of an estrogen receptor coactivator complex.

Proc. Natl. Acad. Sci. U.S.A.
Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M.
| Oct 15, 1996
1060.

The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.

Proc. Natl. Acad. Sci. U.S.A.
Yao TP, Ku G, Zhou N, Scully R, Livingston DM.
| Oct 1, 1996